炭疽杆菌菌体蛋白抗体
规格：1mg/1ml
英文名： Bacillus anthraci protein
别名：
储存液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce
克隆类型：Polyclonal
亚型：IgG
纯化方法：affinity purified by Protein A
**原：Whole cell protein of Bacillus anthraci
交叉反应：Bacillusantci
细胞定位：
炭疽杆菌菌体蛋白抗体产品介绍：background: Bacillus anthracis is an aerobic spore forming bacterium that causes anthrax, an acute infectious disease of cattle, sheep, goats, camels, antelopes and other herbivores. Infection can occur in humans when they are exposed to infected animals or tissue from infected animals via three routes: cutaneous, inhalation and gastrointestinal. B. anthracis 炭疽杆菌菌体蛋白抗体spores persist in the soil for many years as they are resistant to heat, cold, radiation, desiccation, and disinfectants. In vivo, B anthracis produces a polypeptide (polyglutamic acid) capsule that protects it from phagocytosis. The virulence factors of B anthracis are its capsule and three component toxin, both encoded on plasmids. Important Note: This product as supplied is intended for research use only, not for 炭疽杆菌菌体蛋白抗体use in human, therapeutic or diagnostic applications. 炭疽杆菌从损伤的皮肤、胃肠粘膜及呼吸道进入人体后，首先在局部繁殖，产生**而致组织及脏器发生出血性浸润、坏死和高度水肿，形成原发性皮肤炭疽、肠炭疽的肺炭疽等。当机体抵抗力降低时，致病菌即迅速沿**管及血管向全身扩散，形成败血症和继发性脑膜炎。皮肤炭疽因缺血及**的作用，真皮的神经纤维发生变化，故病灶处常无明显的疼痛感。炭疽杆菌的**可直接损伤血管的内皮细胞，使血管壁的通透性增加，导致有效血容量减少，微循环灌注量下降，血液呈高凝状态，出现DIC和感染性休克。
炭疽杆菌菌体蛋白抗体产品应用：ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
研究领域：**学 **及病毒
储存条件： Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
来源： Rabbit
外观： Lyophilized or Liquid